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Purpose: The environmental conditions in space, particularly exposure to cosmic radiation, coupled with
decreased mobility, altered glucose metabolism, and hemodynamic changes may promote cardiovascular disease
Therefore, we assessed early vascular aging markers and hemodynamics using a novel oscillometric blood
pressure device.
Methodology: In eight cosmonauts (46.5  5.3 yrs, 77.6  8.2 kg, 176  6.2 cm, 7 men/1woman), we determined
heart rate, peripheral blood pressure, central blood pressure, and pulse wave velocity in the supine position using
an oscillometric brachial device coupled with transfer function analysis. We obtained measurements at baseline
(65–90 days before ﬂight) and four days (Rþ4) and eight days (Rþ8) after return from six months mission on-
board the International Space Station.
Results: Compared to baseline, heart rate increased signiﬁcantly on Rþ4 (58.6  6.4 vs. 70.3  5.2 bpm) but did
not differ on Rþ8. Central systolic blood pressure increased from 112.5  13.5 on baseline to 125.6  18.5 on
Rþ4 and 121.6  9.5 mmHg, albeit showing no statistical signiﬁcance compared to baseline (p ¼ 0.243/0.295).
Peripheral diastolic and systolic as well as central diastolic blood pressure measurements followed this trend.
Pulse wave velocity increased non-signiﬁcantly from baseline (6.7  0.8 m/s) to Rþ4 (7.2  0.8 m/s, p ¼ 0.499)
and stayed elevated on Rþ8 (7.1  0.5 m/s, p ¼ 0.614).
Conclusion: The important ﬁnding of our study is that six months in a near-earth orbit do not lead to clinically
signiﬁcant changes in early vascular ageing biomarkers. However, these ﬁndings cannot be extrapolated to the
conditions encountered in deep space. Non-invasive testing of vascular biomarkers may have utility in detecting
vascular risks during space travel at an early stage.1. Introduction
The extreme environmental conditions in space, particularly exposure
to cosmic radiation, coupled with decreased mobility, altered glucose
metabolism, and hemodynamic changes may promote early vascular
ageing and overt cardiovascular disease [11]. Compared to earth, radi-
ation exposure increases 250-fold on board the International Space Sta-
tion in near-earth orbit [5]. In vitro, radiation induces cardiovascular
damage and atherosclerosis as ﬁnal common path of DNA-damage,
reactive oxygen species formation, cytokine release, and inﬂammationn, Germany.
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vier B.V. This is an open access ar[19]. Epidemiological studies in atomic bomb survivors in Hiroshima and
Nagasaki [7,15], in Russian emergency workers following the Chernobyl
accident [12], and in patients following radiation therapy showed
increased cardiovascular disease prevalence [8]. These observations led
to the recognition of radiation-induced cardiovascular disease. However,
the small number of astronauts and cosmonauts and the limited
follow-up make it difﬁcult relating radiation exposure in space to pre-
mature vascular ageing and clinical cardiovascular events [9]. Increased
larger artery intima media thickness has been reported during but not
after space ﬂight [1]. Another study showed shortened pulse wave transit2019
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ﬂight will include deep space missions, it is crucial to provide a cardio-
vascular health monitoring, which is easy-to-perform, non-invasive and
observer-independent. Such medical devices providing central hemody-
namics and vascular function measurements, are gaining more impor-
tance for cardiovascular risk stratiﬁcation in the clinic [17]. Non-invasive
central blood pressure measurements, estimating blood pressure in the
ascending aorta, appear to have a particularly high prognostic value [13],
which increases further in combination with pulse wave velocity and
arterial stiffness analyses [4,14] in comparison to a risk stratiﬁcation
solely based on peripheral blood pressure. We hypothesized that if
long-term space missions promoted early vascular ageing, pulse wave
velocity and central blood pressure should, both, increase. Therefore, we
assessed central hemodynamics including central blood pressure and
pulse wave velocity before and after long-term spaceﬂight in cosmonauts
using a new easy-to-perform and non-invasive method based on oscil-
lometric, brachial cuff measurements [10,22]. The methodology has
been validated against invasive catheter measurements and showed high
reproducibility with low observer-dependency [10,23].
2. Methodology
In eight cosmonauts (46.5  5.3 yrs, 77.6  8.2 kg, 176  6.2 cm, 7
men/1woman), we obtained automated brachial blood pressure and
vascular measurements (Mobil-O-Graph® PWA, I.E.M GmbH, Stolberg,
Germany). Preﬂight baseline data were obtained between 65 and 90 days
before launch. Following 6 months onboard the International Space
Station, post ﬂight measurements were obtained four (Rþ4) and eight
(Rþ8) days after return. Mean ﬂight duration was 168 days. All mea-
surements were obtained with cosmonauts in the supine position after at
least 10 min of rest to attain steady-state conditions.
The measurement comprises two subsequent procedures. First, a
regular oscillometric blood pressure measurement assessing heart rate
and peripheral arterial systolic and diastolic blood pressure is obtained.
Second, the cuff inﬂates to previously determined diastolic blood pres-
sure and maintains the pressure for several seconds to continuously
record pulse waves traveling underneath the cuff. Then, the device ap-
plies a generalized transfer function, pulse wave analysis, and wave
separation analysis onto the averaged pulse waves for providing esti-
mated aortic pulse wave velocity (PWV), central systolic and diastolic
blood pressure as described elsewhere [10]. Central-to-peripheral sys-
tolic and pulse pressure ampliﬁcation, two-dimensional measures which
are not affected by absolute pressure levels, were also calculated and
normalized for heart rate.
Statistical analysis was done using IBM SPSS Statistics 21 (IBM,
Armonk, New York, USA). The three time points were compared using
one-way ANOVA testing followed by the post-hoc Tamhande test. Level
of signiﬁcance was <0.05. Values are given as mean  standard devia-
tion. The protocol was approved by the ethics committee of the Institute
of Biomedical Problems, Moscow, Russian Federation and the Human
Research Multilateral Review Board of the National Aeronautics and
Space Administration (NASA). All subjects gave written informed con-
sent in accordance with the Declaration of Helsinki.
3. Results
No cosmonaut showed signs or symptoms of cardiovascular disease
during space travel or four and eight days after return to earth. Individual
trends for heart rate, peripheral blood pressure, central blood pressure,
pulse wave velocity, and central to peripheral ampliﬁcation index before
and after space travel are illustrated in Fig. 1 and their mean values are
listed in Table 1.
At baseline, supine heart rate was 58.4  6.5 bpm with a signiﬁcant
increase to 70.3  5.2 bpm (Δ ¼ 11.9 bpm; p < 0.001) four days after
return. The difference was attenuated eight days after return to earth.
Peripheral arterial systolic and diastolic blood pressure followed a similar2trend with a numerical albeit statistically not signiﬁcant increase on day
four and a smaller increase on day eight after return. We observed similar
trends for pulse wave velocity and central arterial systolic and diastolic
blood pressure. Compared to baseline, the values were numerically albeit
statistically not signiﬁcant increased on day four and day eight after re-
turn with the highest level on day four. Central to peripheral systolic and
pulse pressure ampliﬁcation did not change signiﬁcantly over all time
points. Ampliﬁcations normalized to a heart rate of 75 bpm, decreased
numerically on Rþ4with a subsequent increase on Rþ8without reaching
baseline level. Systolic Ampliﬁcation was signiﬁcantly lower on Rþ4
compared to baseline.
However, individual responses varied and some cosmonauts exhibi-
ted modest pulse wave velocity increases that were sustained through
day eight after return. The individual largest increase in central blood
pressure four days after return was 38 mmHg for systolic and 13 mmHg
for diastolic pressure, pulse wave increased at a maximum of 1.5 m/s.
Eight days after return the individual highest increase for central blood
pressure was 31 (systolic), respectively 18 (diastolic) mmHg and 1.1 m/s
for pulse wave velocity.
4. Discussion
The important ﬁnding of our study is that six months in a near-earth
orbit do not lead to clinically signiﬁcant changes in early vascular ageing
biomarkers. Indeed, all cosmonauts showed pulse wave velocities below
10 m/s, which is considered the threshold heralding excess cardiovas-
cular risk [16]. The methodology applied in our study allows detecting
differences in pulse wave velocity as low as 1 m/s with high validity and
a 95%-conﬁdence interval of 0,47 to 0.57 m/s for repeated measure-
ments [10]. Moreover, all other measurements before and after space-
ﬂight remained within the physiological range. Some, such as central
blood pressure, tended to return to baseline values before spaceﬂight
within a few days.
On earth, blood pressure and age are particularly strong predictors of
pulse wave velocity [3]; 2010). In this and in previous studies, blood
pressure and heart rate were increased in the days following return to
earth [2,20]. Concomitant increases in heart rate and blood pressure are
consistent with sympathetic nervous system activation. However, during
prolonged space ﬂight, blood pressure and heart rate tend to decrease.
The response is likely explained by peripheral vasodilation [18]. The
numerical increase in central blood pressure in our study following re-
turn to earth likely resulted from a transient pressor response rather than
pathological vascular remodeling. The notion is supported by our mea-
surements of systolic and pulse pressure ampliﬁcation. The decrease in
normalized ampliﬁcation suggests an increase in the compliance of the
arterial vasculature. The return of the values eight days after return to
earth is also consistent with functional rather than structural vascular
changes, like transient hypervolemia on return to earth. Worsened aortic
compliance and stiffness measurements have been previously observed
after 5–18 days in space [21]. Given the short exposure, it is unlikely that
these changes were due to structural vascular remodeling. The more
prolonged exposure to the extreme environmental conditions in space in
our study is more informative in that regard. Others observed shortened
pulse wave transit times in male astronauts measured at the ﬁngertip [2,
11]. Carotid artery distensibility was also decreased, thus, conﬁrming
increased arterial stiffness [11].
Moreover, carotid artery ultrasound measurements on the Interna-
tional Space Station revealed increased intima-media thickness [1].
Increased intima media thickness is usually considered as a marker for
preclinical cardiovascular disease. Strikingly, a similar change would
require 20–30 years aging on earth. Yet, intima media thickness mea-
surements after space ﬂight were similar to measurements before space
ﬂight. We obtained similar results [1]. Transient intimamedia thickening
in space may reﬂect reversible adaptation to the microgravity environ-
ment rather than pathological vascular remodeling.
The main limitation of our study is the small number of cosmonauts.
Table 1
Pooled subject values represented as mean  standard deviation. The p-value to the right of Rþ4 and Rþ8 represent the level of signiﬁcance (p < 0.05) with respect to
PRE. HR: heart rate; PWV: pulse wave velocity; SBPP/DBPP: Peripheral systolic and diastolic blood pressure; SBPC/DBPC: Central systolic and diastolic blood pressure;
Ampliﬁcation systolic: absolute pressure independent ampliﬁcation from central to peripheral for systolic measurements; Ampliﬁcation pp: Ampliﬁcation for pulse
pressure from central to peripheral; HR75: Ampliﬁcation normalized to a heart rate of 75 bpm; PRE: Baseline measurements 65–90 days before ﬂight; Rþ4/Rþ8:
postﬂight measurement four/eight days after return.
PRE Rþ4 p-value Rþ8 p-value
HR [bpm] 58.6  6.4 * 70.3  5.2 <0.0001 66.1  8.5 0.087
PWV [m/s] 6.7  0.8 7.2  0.8 0.499 7.0  0.5 0.614
SBPP [mmHg] 120.1  13 134.1  19.7 0.219 127.4  11.5 0.376
DBPP [mmHg] 78.9  9.1 85.3  7.8 0.213 82.6  8.1 0.646
SBPC [mmHg] 112.5  13.5 125.6  18.5 0.243 120.3  9.8 0.295
DBPC [mmHg] 79.7  9.9 86.4  8.4 0.246 83.3  8.7 0.717
Ampliﬁcation systolic 1.06  0.04 1.07  0.03 0.984 1.06  0.04 0.989
Ampliﬁcation systolic HR75 1.36  0.18 1.15  0.1 0.003 1.22  0.14 0.103
Ampliﬁcation pp 1.24  0.15 1.27  0.14 0.951 1.21  0.13 0.918
Ampliﬁcation pp HR 75 1.6  0.34 1.37  0.19 0.119 1.39  0.17 0.145
Fig. 1. Individual heart rate (A), pulse wave velocity (B), central systolic blood pressure (C), peripheral systolic blood pressure (D), central diastolic blood pressure (E),
and peripheral diastolic blood pressure (F), all sorted by time point. PRE: 90 to 65 days before ﬂight; Rþ4/Rþ8: post ﬂight measurements four/eight days after return.
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prospective power-calculation was not available. However, we per-
formed a post-hoc power analysis based on our data. Given the observed
standard deviation, 32 cosmonauts would have to be included to detect
a 10 mmHg difference in central systolic blood pressure with alpha ¼
0.05 (Dupont and Plummer 1990). The follow up was too short to detect
delayed onset vascular disease. Indeed, radiation-induced cardiovascu-
lar disease may occur many years following radiation exposure.
Nevertheless, the fact that we did not observe clinical relevant or sig-
niﬁcant changes is reassuring. Finally, all central hemodynamic pa-
rameters are calculated based on oscillometric brachial cuff
measurements using unpublished algorithms [10,22]. The applied
mathematical model is based on assumptions that may not be applicable
after space travel. Aortic pulse wave velocity estimations include age,
central systolic blood pressure and aortic characteristic impedance.
Aortic characteristic impedance is estimated in this model, which could
confound the analysis.
Despite these issues we suggest that six months in near earth orbit do
not lead to medically relevant changes in early vascular ageing bio-
markers immediately following return to earth. Studies conducted in
cosmonauts staying in near earth orbit cannot be extrapolated to the
conditions encountered in deep space. Indeed, the earth's magnetic ﬁeld
shields much of the cosmic radiation. For long-term missions in deep
space and for individuals ﬂying repeatedly, it may be prudent monitoring
vascular health biomarkers regularly. A non-invasive and easy to perform
test like the one applied in our study holds promise to meet these re-
quirements. Our study may also have implications for cardiovascular
medicine on earth. The rapid reversal of some of the so-called early
vascular ageing biomarkers suggests that the methodologies have limi-
tations in differentiating physiological vascular adaptation from true
preclinical vascular disease.
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